News
EAST HANOVER, NJ, USA I August 11, 2025 I Novartis today announced positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback